Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133549) titled 'Study on the Value of Targeted Fibroblast Activation Protein FAPI PET/MR in Precision Diagnosis and Treatment of Gastric Cancer' on Sept. 29.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Gastric cancer
Intervention:
Gold Standard:pathological results from surgical resection or gastroscopic
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Target condition:100;Difficult condition:10
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj....